AstraZeneca (AZN) News Today £117.90 -20.00 (-0.17%) As of 12:09 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock AZN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Deutsche Bank Sticks to Their Hold Rating for AstraZeneca (AZN)August 28 at 9:19 PM | theglobeandmail.comAstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025August 28 at 6:31 AM | insidermonkey.comAstraZeneca (LON:AZN) Stock Price Crosses Above 200-Day Moving Average - What's Next?August 25, 2025 | marketbeat.comSweden's Wallenberg groups launch joint AI companyAugust 22, 2025 | msn.comThe Capital Group Adjusts AstraZeneca HoldingsAugust 21, 2025 | tipranks.comAstraZeneca advances Wednesday, outperforms marketAugust 20, 2025 | marketwatch.comInsider Selling: AstraZeneca PLC (LON:AZN) Insider Sells 9,563 Shares of StockAugust 20, 2025 | marketbeat.comAradhana Sarin Sells 9,563 Shares of AstraZeneca (LON:AZN) StockAugust 20, 2025 | americanbankingnews.comAstraZeneca rises Monday, outperforms marketAugust 19, 2025 | marketwatch.comAstraZeneca CFO Sells Company SharesAugust 19, 2025 | msn.comAstraZeneca PLC (LON:AZN) Insider Aradhana Sarin Sells 9,563 SharesAugust 19, 2025 | insidertrades.comFibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZenecaAugust 18, 2025 | msn.comAstraZeneca (LON:AZN) Shares Pass Above Two Hundred Day Moving Average - Here's WhyAugust 16, 2025 | marketbeat.comAstraZeneca Launches At-Home FluMist as Vaccination Rate DropsAugust 15, 2025 | msn.comAstraZeneca’s Innovative Approach in Cancer Treatment: A Study UpdateAugust 15, 2025 | msn.comAstraZeneca’s CAPItello-292 Study: A New Frontier in Breast Cancer TreatmentAugust 15, 2025 | msn.comAstraZeneca’s Phase III Study: Baxdrostat and Dapagliflozin Combination for Heart Failure PreventionAugust 14, 2025 | msn.comAstraZeneca’s CAPItello-292 Study: A New Hope for Advanced Breast Cancer TreatmentAugust 13, 2025 | msn.comAstraZeneca’s ATHENA Study: A New Frontier in CAR-T Therapy for Liver CancerAugust 13, 2025 | msn.comRevna Biosciences and AstraZeneca Increase Access to Lung Cancer Treatment in GhanaAugust 11, 2025 | msn.comAstraZeneca: Great Portfolio, But Not A Great PriceAugust 11, 2025 | seekingalpha.comAstraZeneca (LON:AZN) Stock Price Passes Above 200 Day Moving Average - What's Next?August 8, 2025 | marketbeat.comAstraZeneca's (AZN) Hold Rating Reiterated at Deutsche Bank AktiengesellschaftJuly 31, 2025 | marketbeat.comShore Capital Sticks to Their Buy Rating for AstraZeneca (AZN)July 30, 2025 | theglobeandmail.comShore Capital Reaffirms "Buy" Rating for AstraZeneca (LON:AZN)July 30, 2025 | marketbeat.comAstraZeneca (AZN) Receives a Buy from TD CowenJuly 30, 2025 | theglobeandmail.comJefferies Reaffirms Their Hold Rating on AstraZeneca (AZN)July 30, 2025 | theglobeandmail.comAstraZeneca declares $1.03 dividendJuly 29, 2025 | msn.comAstraZeneca reports Q2 core EPS $2.17, up 12% at CERJuly 29, 2025 | msn.comAstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts GrowthJuly 29, 2025 | msn.comAstraZeneca Stock Rises as US, Cancer Drugs Growth Lifts Q2 ResultsJuly 29, 2025 | msn.comAstraZeneca Books Record Quarterly Revenue as Oncology Boosts GrowthJuly 29, 2025 | msn.comFTSE 100 Live: Mixed start for stocks, Games Workshop and AstraZeneca climbJuly 29, 2025 | uk.investing.comAstraZeneca (AZN) Bets Big on U.S. with $50 Billion Manufacturing ExpansionJuly 29, 2025 | msn.comStocks to watch this week: Microsoft, Apple, Shell, AstraZeneca and HSBCJuly 28, 2025 | msn.comStocks to watch next week: Microsoft, Apple, Shell, AstraZeneca and HSBCJuly 25, 2025 | msn.comAstraZeneca’s AZD4144 Study Completion: Market Implications and InsightsJuly 24, 2025 | theglobeandmail.comAstraZeneca's rare immune disorder drug succeeds in advanced trialJuly 24, 2025 | msn.comAstraZeneca succeeds in late-stage trial for myasthenia gravis therapyJuly 24, 2025 | msn.comAstraZeneca (LSE:AZN) Commits US$50 Billion For US Expansion By 2030July 23, 2025 | finance.yahoo.comAstraZeneca (LSE:AZN) Anselamimab Shows Promise In AL Amyloidosis Despite Missing Main EndpointJuly 19, 2025 | finance.yahoo.comAstraZeneca announces Enhertu combination with pertuzumab granted BTD by FDAJuly 18, 2025 | finance.yahoo.comAstraZeneca therapy for clearing protein deposits fails main goal in late-stage studyJuly 17, 2025 | msn.comAstraZeneca’s anselamimab treatment fails to meet main trial goal; shares slipJuly 16, 2025 | uk.investing.comAstraZeneca’s rare disease drug falls short in late-stage trialJuly 16, 2025 | msn.comAstraZeneca drug lowers high blood pressure in late-stage study; shares riseJuly 15, 2025 | msn.comAstraZeneca PLC (AZN) Secures EU Approval for ImfinziJuly 15, 2025 | msn.comAstraZeneca Meets All Key Goals in Phase III Hypertension StudyJuly 15, 2025 | msn.comAstraZeneca (LSE:AZN) Unveils Promising Phase III Results For Baxdrostat In Hypertension TrialJuly 14, 2025 | finance.yahoo.comAstraZeneca slips Friday, underperforms marketJuly 11, 2025 | marketwatch.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼-0.151.03▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼34▲AZN Articles Average Week Get the Latest News and Ratings for AZN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AstraZeneca and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GSK News Ithaca Energy News HUTCHMED News Indivior News Grainger News Bloomsbury Publishing News Origin Enterprises News India Capital Growth News Aura Energy News Alpha Real Trust News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AZN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access